Latest chemotherapy Stories
Is the era of targeted therapy for breast cancer at hand? It could be, said experts at the Lester and Sue Smith Breast Center at Baylor College of Medicine – at least for a certain population of women. In a report that appears online today in the Journal of Clinical Oncology, the researchers have shown that a subset of breast cancer patients who have tumors overexpressing a protein called the human epidermal growth factor receptor 2 (HER-2 positive) may benefit from a combination of...
New book "The Healing Journey of My Bodacious Ta ta's" explores preventative, holistic options for allowing the body to heal itself Houston, Texas (PRWEB) April 08, 2013 When Venus DeMarco was diagnosed with breast cancer, she sought help from conventional means: doctors and specialists. But after weighing her options, DeMarco realized that she didn’t have to go through surgery, chemotherapy or radiation: the only thing she had to do was change her lifestyle. In her...
Among patients with painful chemotherapy-induced peripheral neuropathy, use of the anti-depressant drug duloxetine for 5 weeks resulted in a greater reduction in pain compared with placebo, according to a study in the April 3 issue of JAMA. "Approximately 20 percent to 40 percent of patients with cancer who receive neurotoxic chemotherapy (e.g., taxanes, platinums, vinca alkaloids, bortezomib) will develop painful chemotherapy-induced peripheral neuropathy. Painful chemotherapy-induced...
In a first-of-its-kind experiment using microvesicles generated from mesenchymal bone marrow cells (MSCs) to treat cancer, neurological researchers at Henry Ford Hospital have discovered a novel approach for treatment of tumors. Specifically, the research team found that introducing genetic material produced by MSCs significantly reduced a particularly resistant form of malignant brain tumor in living lab rats. Detroit, Michigan (PRWEB) April 01, 2013 DETROIT – In a first-of-its-kind...
TOKYO, March 28, 2013 /PRNewswire/ -- Anaeropharma Science Inc. announced on March 28 that it has initiated a Phase I clinical trial of APS001F in patients with advanced solid tumors in the United States. The first-in-human dose-escalation trial enrolls patients with advanced and/or metastatic solid tumors whose disease is no longer considered responsive to available treatments. The trial is designed to evaluate safety, tolerability and efficacy of the study agent. About...
PRINCETON, N.J., March 27, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration (FDA) has completed its review and cleared the Investigational New Drug (IND) application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients. Clearance of the IND allows Soligenix to initiate a Phase...
SAN FRANCISCO, March 26, 2013 /PRNewswire/ -- New research adds to the growing body of evidence that modified citrus pectin (MCP), a natural supplement derived from the pith of citrus fruit, has a powerful effect against cancer. In a study just published in the March 2013 issue of the journal Integrative Cancer Therapies, MCP enhanced the anti-cancer effects of two botanical formulas, one for breast cancer and one for prostate cancer. The combination treatment decreased cancer cell...
St. Jude Children's Research Hospital plays key role in research showing that drug shortages erode the quality and increase the cost of cancer care; experts warn that shortages persist despite efforts to fix the problem A national survey of health professionals showed that drug shortages are taking a heavy toll on cancer patients, forcing treatment changes and delays that for some patients meant worse outcomes, more therapy-related complications and higher costs. St. Jude Children's...
GLENVIEW, Ill., March 21, 2013 /PRNewswire-USNewswire/ -- The Hematology/Oncology Pharmacy Association (HOPA) has released a survey of oncology pharmacists which warns that oncology drug shortages happen often and have serious negative consequences on cancer patients in the United States. Published in the April 1, 2013 issue of the American Journal of Health-System Pharmacy, the survey was completed by hematology/oncology pharmacists, who care for cancer patients in all phases of...
St. Jude Children's Research Hospital plays key role in research showing that drug shortages erode the quality and increase the cost of cancer care; experts warn that shortages persist despite efforts to fix the problem MEMPHIS, Tenn., March 21, 2013 /PRNewswire-USNewswire/ -- A national survey of health professionals showed that drug shortages are taking a heavy toll on cancer patients, forcing treatment changes and delays that for some patients meant worse outcomes, more...
Latest chemotherapy Reference Libraries
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...
